Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    Menu

    Tinlarebant

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Belite Bio Announces Doses First Patient In DRAGON II Trial
    Belite Bio Announces Doses First Patient In DRAGON II Trial

    10 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/10/2943626/0/en/Belite-Bio-Announces-First-Patient-Dosed-in-Phase-2-3-DRAGON-II-Trial-of-Tinlarebant-for-the-Treatment-of-Stargardt-Disease.html

    GLOBENEWSWIRE
    10 Sep 2024
    Share Share
    Belite Bio Reports Q2 2024 Results And Corporate Update
    Belite Bio Reports Q2 2024 Results And Corporate Update

    09 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/09/2927935/0/en/Belite-Bio-Reports-Second-Quarter-2024-Financial-Results-and-Provides-a-Corporate-Update.html

    GLOBENEWSWIRE
    09 Aug 2024
    Share Share
    Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant
    Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant

    12 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/12/2897299/0/en/Belite-Bio-Receives-Sakigake-Pioneer-Drug-Designation-of-Tinlarebant-for-Stargardt-Disease-in-Japan.html

    GLOBENEWSWIRE
    12 Jun 2024
    Share Share
    Belite Bio Q1 2024 Financials, Corporate Update
    Belite Bio Q1 2024 Financials, Corporate Update

    13 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/14/2881001/0/en/Belite-Bio-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    13 May 2024
    Share Share
    Belite Bio KOL Webinar On STGD1, GA And Tinlarebant
    Belite Bio KOL Webinar On STGD1, GA And Tinlarebant

    06 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/06/2875803/0/en/Belite-Bio-to-Participate-in-Key-Opinion-Leader-Webinar-to-Discuss-Unmet-Needs-In-Stargardt-Disease-STGD1-and-Geographic-Atrophy-GA-and-Perspectives-On-Tinlarebant.html

    GLOBENEWSWIRE
    06 May 2024
    Share Share
    Belite Presents More Tinlarebant Phase 2 Stargardt Data At ARVO
    Belite Presents More Tinlarebant Phase 2 Stargardt Data At ARVO

    06 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/06/2875783/0/en/Belite-Bio-Presents-Additional-Analysis-from-Phase-2-Study-of-Tinlarebant-in-Stargardt-Disease-at-the-ARVO-Annual-Meeting.html

    GLOBENEWSWIRE
    06 May 2024
    Share Share